On March 3, 2020, Philip M. Rice II, Chief Financial Officer, resigned as a director of Zivo Bioscience, Inc. Mr. Rice's resignation from the Boards of Directors of the company did not result from any disagreement with the company. On March 4, 2020, the company's Board of Directors appointed Andrew A. Dahl, Chief Executive Officer, as a director, to serve in such capacity until his successor is appointed and qualified or until his earlier resignation or removal.